<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Zhen W</submitter><funding>Ludwig Institute for Metastasis Research</funding><funding>NCI NIH HHS</funding><funding>National Institutes of Health</funding><funding>University of Chicago Medicine Comprehensive Cancer Center</funding><funding>NIH HHS</funding><pagination>e2405494</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11891090</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>37(52)</volume><pubmed_abstract>The efficacy of radiotherapy (RT) is limited by inefficient X-ray absorption and reactive oxygen species generation, upregulation of immunosuppressive factors, and a reducing tumor microenvironment (TME). Here, the design of a mitochondria-targeted and digitonin (Dig)-loaded nanoscale metal-organic framework, Th-Ir-DBB/Dig, is reported to overcome these limitations and elicit strong antitumor effects upon low-dose X-ray irradiation. Built from Th&lt;sub>6&lt;/sub>O&lt;sub>4&lt;/sub>(OH)&lt;sub>4&lt;/sub> secondary building units (SBUs) and photosensitizing Ir(DBB)(ppy)&lt;sub>2&lt;/sub> &lt;sup>2+&lt;/sup> (Ir-DBB, DBB = 4,4'-di(4-benzoato)-2,2'-bipyridine; ppy = 2-phenylpyridine) ligands, Th-Ir-DBB exhibits strong RT-radiodynamic therapy (RDT) effects via potent radiosensitization with high-Z SBUs for hydroxyl radical</pubmed_abstract><journal>Advanced materials (Deerfield Beach, Fla.)</journal><pubmed_title>Digitonin-Loaded Nanoscale Metal-Organic Framework for Mitochondria-Targeted Radiotherapy-Radiodynamic Therapy and Disulfidptosis.</pubmed_title><pmcid>PMC11891090</pmcid><funding_grant_id>NIH CCSG: P30 CA014599</funding_grant_id><funding_grant_id>R01 CA253655</funding_grant_id><funding_grant_id>P30 CA014599</funding_grant_id><funding_grant_id>1R01CA253655</funding_grant_id><pubmed_authors>Blenko AL</pubmed_authors><pubmed_authors>Germanas T</pubmed_authors><pubmed_authors>Zhen W</pubmed_authors><pubmed_authors>Li J</pubmed_authors><pubmed_authors>Fan Y</pubmed_authors><pubmed_authors>Tillman L</pubmed_authors><pubmed_authors>Lin W</pubmed_authors><pubmed_authors>Weichselbaum RR</pubmed_authors></additional><is_claimable>false</is_claimable><name>Digitonin-Loaded Nanoscale Metal-Organic Framework for Mitochondria-Targeted Radiotherapy-Radiodynamic Therapy and Disulfidptosis.</name><description>The efficacy of radiotherapy (RT) is limited by inefficient X-ray absorption and reactive oxygen species generation, upregulation of immunosuppressive factors, and a reducing tumor microenvironment (TME). Here, the design of a mitochondria-targeted and digitonin (Dig)-loaded nanoscale metal-organic framework, Th-Ir-DBB/Dig, is reported to overcome these limitations and elicit strong antitumor effects upon low-dose X-ray irradiation. Built from Th&lt;sub>6&lt;/sub>O&lt;sub>4&lt;/sub>(OH)&lt;sub>4&lt;/sub> secondary building units (SBUs) and photosensitizing Ir(DBB)(ppy)&lt;sub>2&lt;/sub> &lt;sup>2+&lt;/sup> (Ir-DBB, DBB = 4,4'-di(4-benzoato)-2,2'-bipyridine; ppy = 2-phenylpyridine) ligands, Th-Ir-DBB exhibits strong RT-radiodynamic therapy (RDT) effects via potent radiosensitization with high-Z SBUs for hydroxyl radical</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Dec</publication><modification>2026-06-14T03:09:52.126Z</modification><creation>2026-06-14T03:08:08.685Z</creation></dates><accession>S-EPMC11891090</accession><cross_references><pubmed>39252688</pubmed><doi>10.1002/adma.202405494</doi></cross_references></HashMap>